Medacta Group SA (MOVE) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.172x

Based on the latest financial reports, Medacta Group SA (MOVE) has a cash flow conversion efficiency ratio of 0.172x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF72.95 Million ≈ $92.23 Million USD) by net assets (CHF424.61 Million ≈ $536.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Medacta Group SA (MOVE) liquidity interval to measure how many days the company can operate on defensive assets alone.

Medacta Group SA - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Medacta Group SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Medacta Group SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medacta Group SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Park National Corporation NYSE MKT:PRK	0.043x
COFCO Capital Holdings Co Ltd SHE:002423	0.249x
Investco Holding AS IS:INVES	0.002x
WD-40 Company NASDAQ:WDFC	0.038x
Softcat plc F:SF5	0.107x
Seacoast Banking Corporation of Florida NASDAQ:SBCF	0.010x
EQB Inc. TO:EQB	-0.163x
Denison Mines Corp TO:DML	-0.023x

Annual Cash Flow Conversion Efficiency for Medacta Group SA (2016–2024)

The table below shows the annual cash flow conversion efficiency of Medacta Group SA from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Medacta Group SA worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CHF379.66 Million ≈ $480.00 Million	CHF107.14 Million ≈ $135.46 Million	0.282x	+23.97%
2023-12-31	CHF330.04 Million ≈ $417.26 Million	CHF75.13 Million ≈ $94.98 Million	0.228x	-14.95%
2022-12-31	CHF274.65 Million ≈ $347.24 Million	CHF73.51 Million ≈ $92.94 Million	0.268x	+12.08%
2021-12-31	CHF226.40 Million ≈ $286.23 Million	CHF54.06 Million ≈ $68.35 Million	0.239x	-34.00%
2020-12-31	CHF164.72 Million ≈ $208.25 Million	CHF59.59 Million ≈ $75.34 Million	0.362x	+4.57%
2019-12-31	CHF123.23 Million ≈ $155.80 Million	CHF42.63 Million ≈ $53.90 Million	0.346x	-53.60%
2018-12-31	CHF89.07 Million ≈ $112.61 Million	CHF66.41 Million ≈ $83.96 Million	0.746x	+46.94%
2017-12-31	CHF101.67 Million ≈ $128.54 Million	CHF51.59 Million ≈ $65.22 Million	0.507x	+32.33%
2016-12-31	CHF146.87 Million ≈ $185.69 Million	CHF56.31 Million ≈ $71.19 Million	0.383x	--

About Medacta Group SA

SW:MOVE Switzerland Medical Devices

Market Cap

$3.38 Billion

CHF2.68 Billion CHF

Market Cap Rank

#4953 Global

#71 in Switzerland

Share Price

CHF134.20

Change (1 day)

+0.30%

52-Week Range

CHF130.20 - CHF176.00

All Time High

CHF176.00